CA2116684A1 - Acides amines contenant des formulations parenterales pour le traitement de l'hypotension et d'autres pathologies apparentees - Google Patents

Acides amines contenant des formulations parenterales pour le traitement de l'hypotension et d'autres pathologies apparentees

Info

Publication number
CA2116684A1
CA2116684A1 CA002116684A CA2116684A CA2116684A1 CA 2116684 A1 CA2116684 A1 CA 2116684A1 CA 002116684 A CA002116684 A CA 002116684A CA 2116684 A CA2116684 A CA 2116684A CA 2116684 A1 CA2116684 A1 CA 2116684A1
Authority
CA
Canada
Prior art keywords
formulation
arginine
animal
hypotension
free
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002116684A
Other languages
English (en)
Inventor
Robert G. Kilbourn
Owen W. Griffith
Steven S. Gross
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cornell Research Foundation Inc
University of Texas System
Original Assignee
Robert G. Kilbourn
Owen W. Griffith
Steven S. Gross
The Board Of Regents Of The University Of Texas System
Cornell Research Foundation, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/767,265 external-priority patent/US5286739A/en
Priority claimed from US07/902,653 external-priority patent/US5374651A/en
Priority claimed from US07/910,868 external-priority patent/US5334380A/en
Application filed by Robert G. Kilbourn, Owen W. Griffith, Steven S. Gross, The Board Of Regents Of The University Of Texas System, Cornell Research Foundation, Inc. filed Critical Robert G. Kilbourn
Publication of CA2116684A1 publication Critical patent/CA2116684A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
CA002116684A 1991-09-27 1992-09-26 Acides amines contenant des formulations parenterales pour le traitement de l'hypotension et d'autres pathologies apparentees Abandoned CA2116684A1 (fr)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US767,265 1991-09-27
US07/767,265 US5286739A (en) 1991-09-27 1991-09-27 Parenteral formulations for the inhibition of systemic hypotension associated with nitric oxide production or endothelial derived relaxing factor
US902,653 1992-06-23
US07/902,653 US5374651A (en) 1991-09-27 1992-06-23 Methods and compositions for the treatment of hypotension with arginine free essential and essential amino acids and arginine derivatives
US07/910,868 US5334380A (en) 1991-09-27 1992-06-30 Anti-endotoxin, interleukin-1 receptor antagonist and anti-tumor necrosis factor antibody with arginine-free formulations for the treatment of hypotension
US910,868 1992-07-01

Publications (1)

Publication Number Publication Date
CA2116684A1 true CA2116684A1 (fr) 1993-04-01

Family

ID=27419635

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002116684A Abandoned CA2116684A1 (fr) 1991-09-27 1992-09-26 Acides amines contenant des formulations parenterales pour le traitement de l'hypotension et d'autres pathologies apparentees

Country Status (7)

Country Link
EP (1) EP0663826B1 (fr)
JP (1) JPH06510769A (fr)
AT (1) ATE174794T1 (fr)
AU (1) AU664210B2 (fr)
CA (1) CA2116684A1 (fr)
DE (1) DE69228006T2 (fr)
WO (1) WO1993005780A1 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5334380A (en) * 1991-09-27 1994-08-02 Board Of Regents, The University Of Texas System Anti-endotoxin, interleukin-1 receptor antagonist and anti-tumor necrosis factor antibody with arginine-free formulations for the treatment of hypotension
US5356873A (en) * 1992-11-05 1994-10-18 Clintec Nutrition Co. Method for providing nutritional requirements to patients having a chronic inflammation reaction
AU5040493A (en) * 1992-11-30 1994-06-09 Transcend Therapeutics, Inc Method for treating systemic inflammatory response syndrome
US5312831A (en) * 1993-05-12 1994-05-17 American Cyanamid Company Urethanes and ureas that induce cytokine production
DE4407484A1 (de) * 1993-12-03 1995-06-08 Werner Prof Dr Kreutz Medikament zur Krebs-Therapie
US5656608B1 (en) * 1995-02-23 2000-09-26 Novartis Nutrition Ltd Amino acid compositions and methods of treatment using same
GB9512100D0 (en) * 1995-06-14 1995-08-09 Sandoz Nutrition Ltd Improvements in or relating to organic compounds
PL182205B1 (pl) * 1995-02-23 2001-11-30 Novartis Nutrition Ag Lek do obnizania poziomów czynnika martwicy nowotworu i preparat odzywczy PL PL PL PL
US6284219B1 (en) 1998-06-30 2001-09-04 Phenome Sciences Inc. In vivo determination of metabolic function for use in therapy management
IT1320782B1 (it) * 2000-07-04 2003-12-10 Professional Dietetics Srl Composizioni a base di aminoacidi, atte al trattamentodell'insufficienza cardiaca.
MX2008012723A (es) * 2006-04-04 2008-10-14 Nestec Sa Tratamientos que usan citrulina.
JP6431372B2 (ja) 2011-10-25 2018-11-28 プロシーナ バイオサイエンシーズ リミテッド 抗体製剤および方法
JP2016132622A (ja) * 2015-01-16 2016-07-25 イーエヌ大塚製薬株式会社 敗血症治療又は予防用栄養組成物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2516027A1 (de) * 1973-04-30 1975-10-16 Univ Johns Hopkins Arzneimittel zur foerderung der proteinsynthese und zur konservierung des stickstoffs im koerper
WO1988008259A1 (fr) * 1987-05-01 1988-11-03 Otsuka Pharmaceutical Co., Ltd. Preparation d'emulsion nutritive
FR2615734B1 (fr) * 1987-05-27 1989-12-01 Synthelabo Compositions pharmaceutiques contenant un melange de sels de cetoacides et d'amino-acides utiles pour le traitement de l'uremie
SE8704217D0 (sv) * 1987-10-29 1987-10-29 Vinnars Erik Ab Aminosyrakomposition for parenteral neringstillforsel
US5006559A (en) * 1988-08-31 1991-04-09 Clintec Nutrition Co. Method of use of branched-chain amino acids infusions to influence appetite
US4957938A (en) * 1989-06-21 1990-09-18 Abbott Laboratories Nutritional formulation for the treatment of renal disease

Also Published As

Publication number Publication date
AU664210B2 (en) 1995-11-09
AU2866292A (en) 1993-04-27
DE69228006D1 (de) 1999-02-04
EP0663826B1 (fr) 1998-12-23
ATE174794T1 (de) 1999-01-15
WO1993005780A1 (fr) 1993-04-01
EP0663826A1 (fr) 1995-07-26
JPH06510769A (ja) 1994-12-01
DE69228006T2 (de) 1999-08-12

Similar Documents

Publication Publication Date Title
US5334380A (en) Anti-endotoxin, interleukin-1 receptor antagonist and anti-tumor necrosis factor antibody with arginine-free formulations for the treatment of hypotension
KR100230514B1 (ko) 산화질소 형성 또는 내피 유도 이완 인자와 관련된 전신적 저혈압을 억제하기 위한 아르기닌 길항제
REYNOLDS et al. Immunologic effects of arginine supplementation in tumor-bearing and non-tumor-bearing hosts
US5534545A (en) Parenteral amino acid formulations for the inhibition of systemic hypotension associated with nitric oxide production
US5374651A (en) Methods and compositions for the treatment of hypotension with arginine free essential and essential amino acids and arginine derivatives
US7067489B2 (en) Hematopoietic stimulation
JP2925326B2 (ja) ヒトの窒素保持の促進方法
US4438144A (en) Amino acid preparation and therapy for treatment of stress and injury
US20110312882A1 (en) Methods and compositions for increasing the anaerobic working capacity in tissues
CA2116684A1 (fr) Acides amines contenant des formulations parenterales pour le traitement de l'hypotension et d'autres pathologies apparentees
JP2568286B2 (ja) メラトニン又はその同族体を含有する代謝老化防止剤
US4883661A (en) Use of arginine as an lymphokine synergist
EP0502313A2 (fr) Méthode pour assurer un taux de glutathione intracellulaire adéquat dans les tissus
US5491150A (en) Supplementary therpeutic agents for the treatment of immunodeficiency syndrome
Barbul The role of arginine as an immune modulator
JPH11512747A (ja) 造血幹細胞の動員方法
EP0288478B1 (fr) Utilisation de l'hormone de croissance pour promouvoir la retention d'azote dans des conditions hypocaloriques
Izak et al. The effect of small doses of folic acid in nutritional megaloblastic anemia
US4994492A (en) Treatment of melanoma using N,N-dimethylglycine
WO1982000411A1 (en) Novel amino acid preparation and therapy for treatment of stress and injury
Samlowski et al. Effectiveness and toxicity of protracted nitric oxide synthesis inhibition during IL-2 treatment of mice
Yeshoda et al. Amino-acids and proteins in haemoglobin formation: 1. Tryptophan
CA2340257A1 (fr) Traitement d'etats maladifs
Pines et al. Effect of adrenal cortical extract in hypertensive subjects.
EP0604744A2 (fr) Procédé pour le traitement de sepsis

Legal Events

Date Code Title Description
FZDE Discontinued